KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Other financing activities (2025)

Historic Other financing activities for Dynavax Technologies (DVAX) over the last 3 years, with Q1 2025 value amounting to $46.6 million.

  • Dynavax Technologies' Other financing activities changed N/A to $46.6 million in Q1 2025 from the same period last year, while for Sep 2025 it was $46.6 million, marking a year-over-year change of. This contributed to the annual value of $369.7 million for FY2010, which is 3891.34% up from last year.
  • Per Dynavax Technologies' latest filing, its Other financing activities stood at $46.6 million for Q1 2025.
  • Over the past 5 years, Dynavax Technologies' Other financing activities peaked at $46.6 million during Q1 2025, and registered a low of $46.6 million during Q1 2025.